VECURONIUM BROMIDE

Vecuronium Bromide for Injection, a freeze-dried powder containing 10 mg of the active ingredient per vial, is being procured under solicitation SPE2DP-26-T-3497 by the Department of Defense’s Medical Supply Chain Pharm FSA. The item is identified by National Stock Number 6505-01-258-0983 and is supplied in packages of ten vials, with a total order quantity of six packages distributed across five line items. The contract mandates a minimum of 21 months of remaining shelf life at the time of receipt, with a total shelf life of 24 months that is non-extendable. Storage requirements specify USP controlled room temperature (20–25°C or 68–77°F) and protection from light, with the product to remain in its original carton until use. Packaging must conform to commercial standards as specified in the procurement document, with each unit sealed in a container that protects against damage and breakage, and all shipments packed in suitable commercial exterior containers to ensure safe, low-cost delivery to the destination. All labeling and marking must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and documentation must be submitted via Wide Area WorkFlow (WAWF) for acceptance and payment. Delivery is required within five days of order receipt, with FOB destination terms applying, and inspection and acceptance occur at the point of delivery. The supplier, Hikma Pharmaceuticals USA Inc., must comply with the Berry Amendment and Buy American Act, and all contractors must adhere to cybersecurity requirements under NIST SP 800-171 and applicable hazardous materials handling regulations. The contract includes provisions for whistleblower rights, disclosure of information, cybersecurity incident reporting, and safety issue notification, while ensuring compliance with FAR and DFARS clauses. All offerors must maintain an active SAM registration and represent their small business status, size, and socioeconomic certifications accurately. The solicitation closed on May 26, 2026, with a required delivery date of May 22, 2026, and applies to multiple delivery points including Yokota Air Base in Japan, under the Medical Air Bridge West program.